Beranda › Hipertensi Paru
Uji klinis Hipertensi Paru yang merekrut di AS
55 studi untuk Hipertensi Paru merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Philadelphia, PA10 studi
- Phoenix, AZ9 studi
- Aurora, CO9 studi
- Kansas City, KS8 studi
- Cincinnati, OH8 studi
- New York City, NY8 studi
- Boston, MA8 studi
- Indianapolis, IN8 studi
- Salt Lake City, UT7 studi
- Bend, OR7 studi
- Houston, TX7 studi
- Rochester, MN7 studi
- Charleston, SC7 studi
- Durham, NC6 studi
- Los Angeles, CA6 studi
- Atlanta, GA6 studi
- Louisville, KY6 studi
- San Francisco, CA5 studi
- Washington, DC5 studi
- Chicago, IL5 studi
- Orlando, FL5 studi
- Providence, RI5 studi
- Rochester, NY5 studi
- Tampa, FL4 studi
- Richmond, VA4 studi
- Omaha, NE4 studi
- Ann Arbor, MI4 studi
- Birmingham, AL4 studi
- Nashville, TN4 studi
- Portland, OR4 studi
- Minneapolis, MN4 studi
- Cleveland, OH4 studi
- Denver, CO4 studi
- Albuquerque, NM4 studi
- Dallas, TX4 studi
- Sacramento, CA4 studi
- Pittsburgh, PA4 studi
- Detroit, MI4 studi
- Santa Barbara, CA3 studi
- Gainesville, FL3 studi
Berdasarkan negara bagian
- Alabama4 studi
- Arizona10 studi
- California14 studi
- Colorado12 studi
- Distrik Columbia4 studi
- Florida12 studi
- Georgia6 studi
- Illinois6 studi
- Indiana8 studi
- Kansas8 studi
- Kentucky7 studi
- Louisiana5 studi
- Maryland5 studi
- Massachusetts8 studi
- Michigan9 studi
- Minnesota8 studi
- Missouri5 studi
- Nebraska4 studi
- New Jersey4 studi
- New Mexico4 studi
- New York9 studi
- North Carolina8 studi
- Ohio12 studi
- Oklahoma4 studi
- Oregon10 studi
- Pennsylvania13 studi
- Rhode Island5 studi
- South Carolina9 studi
- Tennessee7 studi
- Texas7 studi
- Utah7 studi
- Virginia6 studi
- Wisconsin3 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT01730092A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07214376Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07179380HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07123779Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07318597Early Intervention With Inhaled Treprostinil Among Patients With Exercise-Induced Pulmonary Hypertension (EPIH)
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07837830Natural History of Sickle Cell Disease
Menerima pesertaStudi observasional
Usia 2 hingga 90 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT00081523A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
Menerima pesertaFase 3
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07816185Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07473700Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Menerima pesertaFase 3
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07285655A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Menerima pesertaFase 2
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07333183Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07132788DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06388421Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
Menerima pesertaSukarelawan sehat diterima
1 Month – 5 Months · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06373289Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05873387Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT07136623De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
Menerima pesertaFase 4
0 Months – 1 Month · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT05213676Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)
Menerima pesertaFase 4
28 Days · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07322133Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
Menerima pesertaFase 2
Usia 8 hingga 60 · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT03630211An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT07234032A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07175038Xenon MRI Pulm Hypertension
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT04991454Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension
Menerima pesertaFase 1
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06770023The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT07561034Dari ClinicalTrials.gov, data diambil 4 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.